Product Information
SUMATRIPTAN 6 MG/0.5 ML VIAL is a generic product labeled by Eugia US LLC, priced at $14.9345 per ML under NDC 55150017305. Its NADAC has been published 288 times since Mar 31, 2021.
FDA first approved this application on Apr 23, 2013. Its Orange Book therapeutic-equivalence code is AP.
Strength
6 mg/.5mL
Manufacturer
Eugia US LLCNDC
55150017305
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA202758FDA Approved
4/23/2013
TE Code
AP
On Market Since
4/23/2013
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has been published 288 times since Mar 31, 2021, and over the history we have for it it has declined 25.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.9345 per ML |
|---|---|
| All-time high | $22.4070 (Aug 11, 2021) |
| All-time low | $12.4674 (May 22, 2024) |
| 52-week high | $15.2668 |
| 52-week low | $13.7735 |
| Median price | $16.6284 |
| Average price | $16.6417 |
| Largest weekly change | +31.8% (Feb 22, 2023) |
| Weeks tracked | 288 |
| Tracking since | Mar 31, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sumatriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN 6 MG/0.5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 6 MG/0.5 ML VIAL, manufactured by Eugia US LLC, is $14.9345 per ML (NDC 55150017305), effective Sep 30, 2026.
How has the price of SUMATRIPTAN 6 MG/0.5 ML VIAL changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has declined 25.8%. It has been tracked across 288 weekly CMS publications since Mar 31, 2021.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 6 MG/0.5 ML VIAL?
Since Mar 31, 2021, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has ranged from a low of $12.4674 (May 22, 2024) to a high of $22.4070 (Aug 11, 2021), with a median of $16.6284 per ML.
Are there cheaper alternatives to SUMATRIPTAN 6 MG/0.5 ML VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $14.5436 per ML — about 3% below SUMATRIPTAN 6 MG/0.5 ML VIAL.
Who manufactures SUMATRIPTAN 6 MG/0.5 ML VIAL?
SUMATRIPTAN 6 MG/0.5 ML VIAL (NDC 55150017305) is labeled by Eugia US LLC, and CMS classifies it as a generic product.